38.08
price down icon1.70%   -0.66
after-market Handel nachbörslich: 38.08
loading

Veracyte Inc Aktie (VCYT) Neueste Nachrichten

pulisher
Jan 30, 2026

Here's Why Veracyte (VCYT) Is a Great 'Buy the Bottom' Stock Now - Finviz

Jan 30, 2026
pulisher
Jan 28, 2026

Can Veracyte Inc. ride the EV waveQuarterly Portfolio Report & Precise Buy Zone Identification - mfd.ru

Jan 28, 2026
pulisher
Jan 28, 2026

Earnings Miss: Can Veracyte Inc expand into new marketsEarnings Summary Report & Fast Moving Market Watchlists - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 27, 2026

Veracyte, Inc. (VCYT) Stock Analysis: A Diagnostic Leader With 17.49% Potential Upside - DirectorsTalk Interviews

Jan 27, 2026
pulisher
Jan 26, 2026

Veracyte, Inc. (VCYT) sees analyst support as Guggenheim reaffirms buy rating - MSN

Jan 26, 2026
pulisher
Jan 26, 2026

Why Veracyte (VCYT) is Poised to Beat Earnings Estimates Again - primepublishers.com

Jan 26, 2026
pulisher
Jan 26, 2026

Veracyte Inc. (NASDAQ:VCYT) Emerges as a Prime Affordable Growth Candidate - Chartmill

Jan 26, 2026
pulisher
Jan 24, 2026

Stronger‑Than‑Expected Revenue Outlook Might Change The Case For Investing In Veracyte (VCYT) - simplywall.st

Jan 24, 2026
pulisher
Jan 22, 2026

Swing Trade: What is the dividend yield of TriSalus Life Sciences Inc Equity WarrantJuly 2025 WrapUp & Verified Entry Point Signals - baoquankhu1.vn

Jan 22, 2026
pulisher
Jan 22, 2026

Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Jan 22, 2026
pulisher
Jan 22, 2026

Assessing Veracyte (VCYT) Valuation As Recent Momentum Meets An Expensive P/E Ratio - Sahm

Jan 22, 2026
pulisher
Jan 22, 2026

Is Veracyte’s (VCYT) Confident Double‑Digit Revenue Outlook Altering The Investment Case For Investors? - Yahoo Finance

Jan 22, 2026
pulisher
Jan 22, 2026

Veracyte, Inc. (VCYT) Sees Analyst Support as Guggenheim Reaffirms Buy Rating - Finviz

Jan 22, 2026
pulisher
Jan 21, 2026

Centene Expands Palliative Care Access in Ohio Through Tuesday Health - Nasdaq

Jan 21, 2026
pulisher
Jan 21, 2026

QRG Capital Management Inc. Sells 106,926 Shares of Veracyte, Inc. $VCYT - MarketBeat

Jan 21, 2026
pulisher
Jan 18, 2026

S P Trends: Is Veracyte Inc showing insider buyingTrade Entry Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 17, 2026

State of Alaska Department of Revenue Takes $1.50 Million Position in Veracyte, Inc. $VCYT - MarketBeat

Jan 17, 2026
pulisher
Jan 16, 2026

Trade Recap: Is Veracyte Inc stock a value trapJuly 2025 PostEarnings & Risk Managed Trade Strategies - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 16, 2026

Veracyte: Profitable, De-Risked, And Ready To Run (NASDAQ:VCYT) - Seeking Alpha

Jan 16, 2026
pulisher
Jan 16, 2026

Sumitomo Mitsui Trust Group Inc. Sells 165,094 Shares of Veracyte, Inc. $VCYT - MarketBeat

Jan 16, 2026
pulisher
Jan 16, 2026

SG Americas Securities LLC Increases Stock Position in Veracyte, Inc. $VCYT - MarketBeat

Jan 16, 2026
pulisher
Jan 15, 2026

Veracyte (NASDAQ:VCYT) Cut to Hold at Zacks Research - MarketBeat

Jan 15, 2026
pulisher
Jan 14, 2026

Is Veracyte’s 2026 Growth Guidance And New US Launches Altering The Investment Case For Veracyte (VCYT)? - Sahm

Jan 14, 2026
pulisher
Jan 14, 2026

Louisiana State Employees Retirement System Invests $1.24 Million in Veracyte, Inc. $VCYT - MarketBeat

Jan 14, 2026
pulisher
Jan 14, 2026

Lung Cancer Diagnostics Market Size and Forecast 2025–2033 - Vocal

Jan 14, 2026
pulisher
Jan 13, 2026

Breakout Move: What is the dividend yield of CMMBJuly 2025 Patterns & AI Optimized Trade Strategies - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 13, 2026

Volume Recap: Is Veracyte Inc. stock a top pick in earnings seasonStock Surge & Accurate Trade Setup Notifications - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $44 - 富途牛牛

Jan 13, 2026
pulisher
Jan 12, 2026

Morgan Stanley initiates coverage of Veracyte, Inc. (VCYT) - MSN

Jan 12, 2026
pulisher
Jan 12, 2026

Veracyte stock rating reiterated at Buy by UBS on strong revenue outlook - Investing.com Australia

Jan 12, 2026
pulisher
Jan 12, 2026

Veracyte stock rating reiterated at Buy by UBS on strong revenue outlook By Investing.com - Investing.com India

Jan 12, 2026
pulisher
Jan 12, 2026

Needham reiterates Buy rating on Veracyte stock after strong Q4 preannouncement - Investing.com Nigeria

Jan 12, 2026
pulisher
Jan 12, 2026

Summit Creek Advisors LLC Makes New $8.52 Million Investment in Veracyte, Inc. $VCYT - MarketBeat

Jan 12, 2026
pulisher
Jan 12, 2026

Veracyte stock outlook positive as Leerink reiterates Outperform rating By Investing.com - Investing.com South Africa

Jan 12, 2026
pulisher
Jan 12, 2026

Veracyte stock outlook positive as Leerink reiterates Outperform rating - Investing.com India

Jan 12, 2026
pulisher
Jan 11, 2026

Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results - 01net

Jan 11, 2026
pulisher
Jan 11, 2026

Veracyte (VCYT) Sets Ambitious Revenue Growth Targets for 2026 - GuruFocus

Jan 11, 2026
pulisher
Jan 11, 2026

Veracyte (VCYT) Poised for Growth with New Product Launches in 2 - GuruFocus

Jan 11, 2026
pulisher
Jan 11, 2026

BRIEF-Veracyte Outlook FY Revenue Growth 16% - TradingView — Track All Markets

Jan 11, 2026
pulisher
Jan 10, 2026

Published on: 2026-01-11 01:59:58 - ulpravda.ru

Jan 10, 2026
pulisher
Jan 10, 2026

Veracyte Reports Strong Q3 2025 Financial Performance - MSN

Jan 10, 2026
pulisher
Jan 09, 2026

Market Wrap: Can Veracyte Inc 12V stock reach 200 price targetJuly 2025 Final Week & Precise Buy Zone Identification - Bộ Nội Vụ

Jan 09, 2026
pulisher
Jan 09, 2026

Can Veracyte Inc. (12V) stock reach $200 price targetJuly 2025 Weekly Recap & AI Driven Price Predictions - Улправда

Jan 09, 2026
pulisher
Jan 09, 2026

Veracyte, Inc. (NASDAQ:VCYT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

Why Veracyte Inc. stock could outperform in 2025July 2025 Decliners & Low Risk Growth Stock Ideas - Улправда

Jan 09, 2026
diagnostics_research WAT
$370.72
price down icon 1.19%
$144.81
price down icon 3.26%
diagnostics_research LH
$271.52
price up icon 0.63%
diagnostics_research MTD
$1,373.24
price down icon 1.40%
$231.14
price down icon 0.15%
diagnostics_research A
$133.85
price up icon 0.44%
Kapitalisierung:     |  Volumen (24h):